Basket cover image
15 handpicked stocks

Beyond The Barrel: The Energy Efficiency Play

Suncor Energy offset the impact of lower oil prices by increasing its production to record levels, showcasing a path to profitability in a challenging market. This creates an investment opportunity in companies that provide the essential technologies and services enabling energy producers to maximize their operational efficiency and output.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+5

Author avatar

Han Tan | Market Analyst

Updated 3 days ago | Published at août 6

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

FET

Forum Energy Technologies, Inc.

FET

Current price

$14.00

ERII

Energy Recovery Inc

ERII

Current price

$14.42

CETY

Clean Energy Technologies Inc

CETY

Current price

$0.25

About This Group of Stocks

1

Our Expert Thinking

Suncor Energy's record production levels despite lower oil prices reveal a critical industry shift. Energy producers are prioritising operational efficiency over price dependency, creating demand for companies that provide the essential technologies and services enabling this transformation.

2

What You Need to Know

This group focuses on the enablers of energy efficiency rather than traditional oil and gas producers. These companies provide advanced drilling technologies, AI-powered process optimisation, and high-output equipment that help energy producers maximise their operational performance.

3

Why These Stocks

Each company was handpicked by professional analysts based on their role in the energy efficiency ecosystem. They represent tactical exposure to the growing demand for solutions that help energy producers boost productivity and maintain profitability in challenging market conditions.

12 Month Growth Potential

Use the growth calculator to see how much investing in these assets could return over one year.

If you invested across these assets:

in 12 months it could be worth:

$1,000.00

+95.41%

Group Performance Snapshot

95.41%

Average 12 Month Profit

On average, analysts expect assets in this group to grow 95.41% over the next year.

9 of 14

Stocks Rated Buy by Analysts

9 of 14 assets in this group are rated Buy by professional analysts.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

Efficiency Revolution Underway

Energy producers are shifting focus from price dependency to operational excellence. This creates rising demand for the technologies and services that make maximum output possible.

🎯

Strategic Market Positioning

These companies provide the essential tools that energy producers need to thrive in challenging market conditions. They're positioned at the heart of an industry transformation.

📈

Growth Beyond Oil Prices

Unlike traditional energy investments, these stocks benefit from the industry's drive for efficiency regardless of commodity price fluctuations. It's about doing more with what you have.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

The New Cost of Compliance: Investing in HR Tech

The New Cost of Compliance: Investing in HR Tech

Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.

View stocks
GLP-1s Target Liver Disease

GLP-1s Target Liver Disease

The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.

View stocks
Pharma's Digital Prescription

Pharma's Digital Prescription

Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.

View stocks
View All Stock Groups

Frequently Asked Questions

Everything you need to know about the product and billing.